Recurrence: all 3,523 studies

Page 21 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.

• A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)Active, not recruitingNCT04404660Phase 1/2
• Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary TumorsCompletedNCT04400357Not applicable
• A Study of Belantamab Mafodotin in Multiple Myeloma Participants With Normal and Impaired Hepatic FunctionWithdrawnNCT04398680Phase 1
• Bintrafusp Alfa in Previously Treated Patients With R/M Non-keratinizing NPCCompletedNCT04396886Phase 2
• Measurement of Lung Area at Chest Radiography to Define the Prognosis in Newborns With CDHStatus unknownNCT04396028
• CAD/CAM Fixed Retainers vs. Conventional Multistranded Fixed Retainers in Orthodontic Patients. Comparison of Stability, Retainer Failure Rate, Adverse Effects, Cost-effectiveness, and Patient Satisfaction. A Randomized Controlled Clinical TrialActive, not recruitingNCT04389879Not applicable
• Myeloid-derived Suppressor Cells (MDSCs) in OSCC PatientsStatus unknownNCT04387682Not applicable
• Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple SclerosisStatus unknownNCT04380220
• Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With OcrelizumabCompletedNCT04377555Phase 4
• Embolization of the Middle Meningeal Artery for the Prevention of Chronic Subdural Hematoma Recurrence in High Risk Patients (EMPROTECT)CompletedNCT04372147Not applicable
• Rituximab Plus Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaCompletedNCT04361409Phase 1
• Lurbinectedin (PM01183) Combined With Pembrolizumab in Small Cell Lung Cancer.CompletedNCT04358237Phase 1/2
• Laparoscopic Versus Open Repair of Bilateral Primary Inguinal HerniaCompletedNCT04357665Not applicable
• Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell TraitCompletedNCT04349189
• Natural Killer-cell Therapy for Acute Myeloid LeukemiaTerminatedNCT04347616Phase 1/2
• Tagraxofusp in Patients With CD123+ or With BPDCN-IPh-like Acute Myeloid LeukemiaTerminatedNCT04342962Phase 2
• Phase I Study of Marizomib + Panobinostat for Children With DIPGTerminatedNCT04341311Phase 1
• Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid TumorsActive, not recruitingNCT04337177Phase 1
• Tuberculosis (TB) AftermathCompletedNCT04333485Not applicable
• Outcome Analysis of Aspirin in Liver TransplantationStatus unknownNCT04327427
• Postoperative Complication After Free Flap Reconstruction for Head and Neck CancerCompletedNCT04326088
• Frequency of Functional Gastrointestinal Disorders in ChildrenStatus unknownNCT04320550
• Anal Fistula Plug, a Retrospective StudyCompletedNCT04319861Not applicable
• FDG and FDOPA PET Demonstration of Functional Brain AbnormalitiesStatus unknownNCT04315584Early Phase 1
• Follow Up of High Risk Hodgkin Lymphoma in First Complete RemissionCompletedNCT04298619
• Lorlatinib Combinations in Lung CancerStatus unknownNCT04292119Phase 1/2
• A Phase Ib Combination Study of Rituximab, TinostamustinEAnd CHeckpoint Inhibition With Pembrolizumab in Relapsed/Refractory DLBCLWithdrawnNCT04279938Phase 1
• Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid NeoplasmsActive, not recruitingNCT04279847Phase 1
• Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)SuspendedNCT04278768Phase 1/2
• Inflammatory and Endothelial Function Response, and Arrhythmia Recurrence Following Catheter Ablation for Atrial FibrillationWithdrawnNCT04269785Not applicable
• Extended Mesenteric Excision in Ileocolic Resections for Crohn's DiseaseStatus unknownNCT04266600Not applicable
• Transcranial Magnetic Stimulation for Methadone Maintenance Therapy Combined With Methamphetamine AbuseCompletedNCT04264741Not applicable
• PROSPECTIVE STUDY OF PREDISPOSING FACTORS OF REFRACTARY Clostridium Difficile INFECTION. INFLUENCE OF THE GUT MICROBIOMAStatus unknownNCT04259931
• A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL)Active, not recruitingNCT04245839Phase 2
• Follow-up Protocol of Colorectal Endoscopic Mucosal Resection ScarsCompletedNCT04239365Not applicable
• Ketamine Long Therm Follow Up StudyStatus unknownNCT04238039
• Intense Monitoring Study on TyvytStatus unknownNCT04237233
• Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomyTerminatedNCT04234399
• Lenalidomide and Sintilimab for Relapsed/Refractory NK/T-cell LymphomaStatus unknownNCT04231370Phase 2
• Mesh Versus Suture Repair in Umbilical Hernias - A Multicenter TrialCompletedNCT04231071Not applicable
• Health Outcomes Via Positive Engagement in SchizophreniaActive, not recruitingNCT04230590
• A Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Acute Lymphoblastic LeukemiaCompletedNCT04230473Phase 1
• Biomarkers of P. Vivax RelapseStatus unknownNCT04228315Not applicable
• Serological Screen and Treat Trial for Plasmodium VivaxStatus unknownNCT04223674Not applicable
• Safety of Autologous Humanized Anti-CD19 and Anti-CD20 Dual Specific CAR-T Cells in Adult Patients With Diffuse Large B-cell LymphomaStatus unknownNCT04215016Phase 1
• A Study of AZD0466 in Patients With Advanced Hematologic or Solid TumorsTerminatedNCT04214093Phase 1
• A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and LymphomaStatus unknownNCT04204161Phase 1
• The Finnish Study of Intraoperative Irrigation Versus Drain Alone After Evacuation of Chronic Subdural Hematoma (FINISH)CompletedNCT04203550Not applicable
• A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia)CompletedNCT04198415
• Humanized CAR-T Cells of Anti-BCAM and Anti-CD19 Against Relapsed and Refractory Multiple MyelomaStatus unknownNCT04194931Phase 1
• Incisional Hernia Repair Long-term OutcomesCompletedNCT04192838Not applicable
• Intraoperative HPV Testing EvaluationStatus unknownNCT04190472
• A Study of CS1001 in Subjects With Esophageal Squamous Cell CarcinomaCompletedNCT04187352Phase 3
• Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care SettingsCompletedNCT04186884
• Long-term Follow-up After Surgical Treatment for GERD (Gastroesophageal Reflux Disease)CompletedNCT04182178
• Comparison of the Efficacy, Safety, and Relapse of ECT to ECT Plus Agomelatine for Depressed PatientsCompletedNCT04181567Phase 4
• A Study of the Safety and Tolerability of ABBV-467 in Adult Participants With Relapsed/Refractory (R/R) Multiple MyelomaTerminatedNCT04178902Phase 1
• Hypermethylation of VTRNA2-1 Promoter in HCC OutcomeCompletedNCT04177316
• Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MMActive, not recruitingNCT04176718Phase 2
• A China Bridging Study of Ivosidenib in r/r AML Subjects With an IDH1 MutationCompletedNCT04176393Phase 1
• RAPA-201 T Cell Therapy for Relapsed, Refractory Multiple MyelomaCompletedNCT04176380Phase 2
• Phase I Study of Radiolabeled OTSA101-DTPA in Patients With Relapsed or Refractory Synovial SarcomaTerminatedNCT04176016Phase 1
• TEAM-Trial: Targeting Epigenetic Therapy Resistance in AML With BortezomibCompletedNCT04173585Phase 2
• The Clinical Study of CD20 CAR-T Cells in Patients With Relapsed and Refractory B Cell Non-Hodgkin LymphomaStatus unknownNCT04169932Early Phase 1
• Study of Brexucabtagene Autoleucel (KTE-X19) for the Treatment of Individuals With Relapsed/Refractory B-Cell MalignanciesApproved for marketingNCT04162756
• Laboratory Model for Relapse to Sedentary BehaviorCompletedNCT04161040Not applicable
• Impact of Short-course Colchicine Versus Placebo After Pulmonary Vein Isolation (IMPROVE-PVI Pilot)CompletedNCT04160117Phase 3
• Charité HT-ProstateStatus unknownNCT04159051Not applicable
• Study of Anitocabtagene-autoleucel in Participants With Relapsed Refractory Multiple MyelomaActive, not recruitingNCT04155749Phase 1
• Immuno-Oncology Drugs Elotuzumab, Anti-LAG-3 and Anti-TIGITTerminatedNCT04150965Phase 1/2
• Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)Active, not recruitingNCT04150497Phase 1/2
• Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AMLCompletedNCT04139434Phase 1
• NKTR-255 in Relapsed/Refractory Multiple Myeloma & Non-Hodgkin LymphomaCompletedNCT04136756Phase 1
• Usefulness of the Artery First Approach in Pancreatic Cancer SurgeryStatus unknownNCT04136522Not applicable
• the Effect of Vitamin D in Crohn's DiseaseStatus unknownNCT04134065Early Phase 1
• Bladder Perforation Post-TURBT: Definition, Incidence and Natural HistoryStudyStatus unknownNCT04129606Not applicable
• High-risk Recurrent or Second Primary HNSCC With PD-1 Antibody Adjuvant After Salvage Surgery(RePASS)Status unknownNCT04126460Phase 2
• Thalidomide, Cyclophosphamide and Dexamethasone for Recurrent/Refractory Adult Langerhans Cell HistiocytosisStatus unknownNCT04120519Phase 2
• Follow up of Patients After a Visit to Tourcoing Emergency Department for an Ankle SprainCompletedNCT04114552
• An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 When Administered Alone and in Combination With Low-Dose Cytarabine (LDAC) or Decitabine in Patients With Acute Myeloid Leukemia (AML)TerminatedNCT04113616Phase 1/2
• Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell LymphomaCompletedNCT04113226Phase 2
• Lenalidomide Observational Study in Patients With Mantle Lymphoma in Relapse/Refraction. Spanish Programme RRMCL Results.Status unknownNCT04109872
• A Phase Ib Study of YY-20394 in Patients With Relapsed or Refractory Peripheral T-Cell LymphomaStatus unknownNCT04108325Phase 1
• Surgical and Oncologic Outcomes After Robotic Nipple Sparing Mastectomy and Immediate ReconstructionCompletedNCT04108117
• Napoleon Trial: Optimal Treatment for Recurrent Haemorrhoidal DiseaseStatus unknownNCT04101773Not applicable
• Study of Enasidenib and Venetoclax in IDH2-Mutated Blood CancersTerminatedNCT04092179Phase 1/2
• Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of CC-95775 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin LymphomaCompletedNCT04089527Phase 1
• CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins LymphomaActive, not recruitingNCT04089215Phase 2
• PET/MRI Study on the Neurological Mechanism of rTMS Treatment for Heroin AddictionStatus unknownNCT04086459Not applicable
• IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid LeukemiaActive, not recruitingNCT04086264Phase 1/2
• Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid TumorsCompletedNCT04084951Phase 1
• Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic AnemiaCompletedNCT04083014Phase 2
• A Study of Imvotamab Monotherapy and in Combination in Subjects With Relapsed/Refractory Non-Hodgkin LymphomaTerminatedNCT04082936Phase 1/2
• LY3214996 in Patients With AML Who Are Not Candidates for Standard TherapyCompletedNCT04081259Phase 1
• Mindfulness Intervention and Relapse in PsychosisCompletedNCT04060498Not applicable
• PCRC-Supported Legacy Intervention in Pediatric Palliative CareCompletedNCT04059393Not applicable
• Study of A-319 in Patients With Relapsed or Refractory B-cell LymphomaStatus unknownNCT04056975Phase 1
• Financial Distress in Advanced Cancer PatientsActive, not recruitingNCT04053517
• A Single-Arm, Expanded Access Study of Zanubrutinib in Participants With B-cell MalignanciesNo longer availableNCT04052854
• A Phase 1 Trial of OPB-111077 in Combination With Bendamustine and Rituximab in Patients With r/r DLBCLCompletedNCT04049825Phase 1

← Recurrence overview